GNLX · NASDAQ
GENELUX (GNLX) Stock Price & Fundamentals
GENELUX (GNLX) closed at $140.51 on Oct 9, 2026, up 1.01% from the previous close of $139.10.
Share price, past year
1Y +28.51%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $140.51 |
| Sep 30, 2026 | $138.23 |
| Aug 31, 2026 | $137.14 |
| Jul 31, 2026 | $125.29 |
| Jun 30, 2026 | $128.57 |
| May 29, 2026 | $136.96 |
| Apr 30, 2026 | $135.47 |
| Mar 31, 2026 | $126.43 |
| Feb 27, 2026 | $122.65 |
| Jan 30, 2026 | $123.30 |
| Dec 31, 2025 | $116.80 |
| Nov 28, 2025 | $109.65 |
| Oct 31, 2025 | $106.14 |
Key statistics
- Market cap
- $6.34B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.86
- Revenue (TTM)
- —
- Net income (TTM)
- −$35.60M
- Shares outstanding
- 45.1M
- Dividend yield
- —
- 52-week range
- $106.14 – $141.28
GENELUX's market cap is $6.34B, based on a share price of $140.51 and 45.1M shares outstanding as of Jun 30, 2026.
Financials
GENELUX reported revenue of $8.00K for fiscal 2025, unchanged 0.00% from fiscal 2024.
GENELUX reported a net loss of $32.15M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $8.00K | 0.0% | −$32.15M | −401,812.5% | −$0.86 | −$26.37M |
| FY2024ended Dec 31, 2024 | $8.00K | −95.3% | −$29.87M | −373,362.5% | −$0.95 | −$21.61M |
| FY2023ended Dec 31, 2023 | $170.00K | −98.5% | −$28.30M | −16,645.3% | −$1.16 | −$21.30M |
| FY2022ended Dec 31, 2022 | $11.07M | — | −$5.21M | −47.1% | −$0.57 | −$3.62M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2024ended Mar 31, 2024 | $8.00K | — | — |
| Q1 FY2023ended Mar 31, 2023 | $170.00K | — | — |
| Q3 FY2022ended Sep 30, 2022 | $11.00M | — | — |
Company profile
- Name
- GENELUX Corp
- Ticker
- GNLX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 2625 Townsgate Road, Suite 230, Westlake Village, CA 91361
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001231457
Recent SEC filings
- Aug 13, 2026
- Jun 22, 2026
- May 7, 2026
- Mar 19, 2026
- Mar 19, 2026
- Feb 2, 2026
- Jan 8, 2026
- Jan 5, 2026
Frequently asked questions
What is GENELUX's stock price?
GENELUX (GNLX) closed at $140.51 on Oct 9, 2026, up 1.01% from the previous close of $139.10.
What is GENELUX's market cap?
GENELUX's market cap is $6.34B, based on a share price of $140.51 and 45.1M shares outstanding as of Jun 30, 2026.
How much revenue does GENELUX make?
GENELUX reported revenue of $8.00K for fiscal 2025, unchanged 0.00% from fiscal 2024.
Does GENELUX pay a dividend?
GENELUX's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from GENELUX Corp's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures